Zhu S, Chen J, Diamond S
Arterioscler Thromb Vasc Biol. 2018; 38(7):1528-1536.
PMID: 29724819
PMC: 6023760.
DOI: 10.1161/ATVBAHA.118.310906.
Protopopova A, Litvinov R, Galanakis D, Nagaswami C, Barinov N, Mukhitov A
Nanoscale. 2017; 9(36):13707-13716.
PMID: 28884176
PMC: 6501582.
DOI: 10.1039/c7nr04413e.
Walden M, Edwards J, Dziewulska A, Bergmann R, Saalbach G, Kan S
Elife. 2015; 4.
PMID: 26032562
PMC: 4450167.
DOI: 10.7554/eLife.06638.
Schachtrup C, Ryu J, Helmrick M, Vagena E, Galanakis D, Degen J
J Neurosci. 2010; 30(17):5843-54.
PMID: 20427645
PMC: 2871011.
DOI: 10.1523/JNEUROSCI.0137-10.2010.
Martinez J, HOLBURN R, Shapiro S, ERSLEV A
J Clin Invest. 1974; 53(2):600-11.
PMID: 11344575
PMC: 301504.
DOI: 10.1172/JCI107595.
Influence of a natural and a synthetic inhibitor of factor XIIIa on fibrin clot rheology.
Ryan E, Mockros L, Stern A, Lorand L
Biophys J. 1999; 77(5):2827-36.
PMID: 10545380
PMC: 1300554.
DOI: 10.1016/S0006-3495(99)77114-6.
The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome".
Mosesson M, Siebenlist K, Hainfeld J, Wall J, Soria J, Soria C
J Clin Invest. 1996; 97(10):2342-50.
PMID: 8636415
PMC: 507315.
DOI: 10.1172/JCI118677.
Measurement of desarginine fibrinopeptide B in human blood.
Eckhardt T, Nossel H, Hurlet-Jensen A, La Gamma K, Owen J, Auerbach M
J Clin Invest. 1981; 67(3):809-16.
PMID: 7204556
PMC: 370632.
DOI: 10.1172/JCI110098.
Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma').
Wolfenstein-Todel C, Mosesson M
Proc Natl Acad Sci U S A. 1980; 77(9):5069-73.
PMID: 6933547
PMC: 349997.
DOI: 10.1073/pnas.77.9.5069.
Fibrin-mediated vascular injury. Identification of fibrin peptides that mediate endothelial cell retraction.
Rowland F, Donovan M, Picciano P, Wilner G, Kreutzer D
Am J Pathol. 1984; 117(3):418-28.
PMID: 6507588
PMC: 1900580.
Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications.
Gaffney P
J Clin Pathol Suppl (R Coll Pathol). 1980; 14:10-7.
PMID: 6448869
PMC: 1347099.
In vivo behavior of fibrinogen fragment D in experimental renal, hepatic and reticuloendothelial dysfunction.
Hayne O, Sherman L
Am J Pathol. 1973; 71(2):219-38.
PMID: 4713941
PMC: 1903957.
Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure.
HARPEL P
J Exp Med. 1973; 138(3):508-21.
PMID: 4269559
PMC: 2139409.
DOI: 10.1084/jem.138.3.508.
Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes.
HARPEL P, Mosesson M
J Clin Invest. 1973; 52(9):2175-84.
PMID: 4269529
PMC: 333018.
DOI: 10.1172/JCI107402.
The number of D and E regions in the fibrinogen molecule.
Plow E, Edgington T
Proc Natl Acad Sci U S A. 1974; 71(1):158-62.
PMID: 4129800
PMC: 387956.
DOI: 10.1073/pnas.71.1.158.
Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.
Plow E, Edgington T
J Clin Invest. 1973; 52(2):273-82.
PMID: 4119160
PMC: 302256.
DOI: 10.1172/JCI107183.
Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
Goodwin C, Kakkar V, Scully M
Biochem J. 1992; 281 ( Pt 3):613-8.
PMID: 1531588
PMC: 1130733.
DOI: 10.1042/bj2810613.
Studies on the structural abnormality of fibrinogen Paris I.
Mosesson M, Amrani D, Menache D
J Clin Invest. 1976; 57(3):782-90.
PMID: 1249208
PMC: 436714.
DOI: 10.1172/JCI108337.
Dysfibrinogenemia associated with liver disease.
Palascak J, Martinez J
J Clin Invest. 1977; 60(1):89-95.
PMID: 874092
PMC: 372346.
DOI: 10.1172/JCI108773.
Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
Nossel H, Wasser J, Kaplan K, LaGamma K, Yudelman I, Canfield R
J Clin Invest. 1979; 64(5):1371-8.
PMID: 500818
PMC: 371285.
DOI: 10.1172/JCI109594.
